SpringerLink
Log in

Improving Antimicrobial Stewardship in Cancer Patients Through Implementation of Clinical Guidelines

  • Antimicrobial Stewardship (A Pakyz, Section Editor)
  • Published:
Current Treatment Options in Infectious Diseases Aims and scope Submit manuscript

Abstract

Purpose of review Antimicrobial stewardship programs have consistently demonstrated the ability to reduce excessive antibiotic utilization, improve the management of targeted diseases, improve outcomes, and reduce costs. Implementation of institutional guidelines are effective options to promote appropriate cost-effective antimicrobial utilization and are recommended by the Infectious Diseases Society of America and the U.S. Centers for Disease Control and Prevention. Cancer patients are frequent users of antimicrobials and present unique challenges for antimicrobial stewardship programs, due to high risk for infection and risk for opportunistic infection and infection with multi-drug-resistant pathogens. Thus, this review evaluates the impact of guidelines on antibiotic management and associated clinical outcomes in cancer patients.

Recent findings This review demonstrates that antibiotic stewardship guidelines targeting cancer patients can improve suboptimal or delayed antimicrobial prescribing and lead to subsequent reductions in mortality and decreased length of hospitalization. Additionally, guideline implementation can reduce excessive durations of unnecessary antimicrobial therapy without adversely impacting clinical outcomes.

Summary Implementation of antibiotic stewardship guidelines could be an effective tool to promote appropriate antibiotic prescribing and reduce unnecessary antibiotic utilization in cancer patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Lin MY, Weinstein RA, Hota B. Delay of active antimicrobial therapy and mortality among patients with bacteremia: impact of severe neutropenia. Antimicrob Agents Chemother. 2008;52(9):3188–94. doi:10.1128/AAC.01553-07.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Barlam TF, Cosgrove SE, Abbo LM, MacDougall C, Schuetz AN, Septimus EJ, et al. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62(10):e51–77. doi:10.1093/cid/ciw118.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Pollack LA, Srinivasan A. Core elements of hospital antibiotic stewardship programs from the Centers for Disease Control and Prevention. Clin Infect Dis. 2014;59(Suppl 3):S97–100. doi:10.1093/cid/ciu542.

    Article  CAS  PubMed  Google Scholar 

  4. •• Okada N, Fushitani S, Azuma M, Nakamura S, Nakamura T, Teraoka K, et al. Clinical evaluation of pharmacist interventions in patients treated with anti-methicillin-resistant Staphylococcus aureus agents in a hematological ward. Biol Pharm Bull. 2016;39(2):295–300. doi:10.1248/bpb.b15-00774. A pharmacist-led intervention aimed at optimizing dosing for vancomycin, teicoplanin, and arbekacin was associated with a decreased hospital length of stay in lymphoma patients.

    Article  CAS  PubMed  Google Scholar 

  5. Lim C, Bawden J, Wing A, Villa-Roel C, Meurer DP, Bullard MJ, et al. Febrile neutropenia in EDs: the role of an electronic clinical practice guideline. Am J Emerg Med. 2012;30(1):5–11, e1-5. doi:10.1016/j.ajem.2010.08.011.

    Article  PubMed  Google Scholar 

  6. • Kroll AL, Corrigan PA, Patel S, Hawks KG. Evaluation of empiric antibiotic de-escalation in febrile neutropenia. J Oncol Pharm Pract. 2016;22(5):696–701. doi:10.1177/1078155215597558. Identified that de-escalation of antibiotics in patients with prolonged neutropenia may be a safe and effective practice to limit antimicrobial exposure.

    Article  CAS  PubMed  Google Scholar 

  7. Vicente M, Al Nahedh M, Parsad S, Knoebel RW, Pisano J, Pettit NN. Impact of a clinical pathway on appropriate empiric vancomycin use in cancer patients with febrile neutropenia. J Oncol Pharm Pract. 2016; doi:10.1177/1078155216668672.

  8. Zuckermann J, Moreira LB, Stoll P, Moreira LM, Kuchenbecker RS, Polanczyk CA. Compliance with a critical pathway for the management of febrile neutropenia and impact on clinical outcomes. Ann Hematol. 2008;87(2):139–45. doi:10.1007/s00277-007-0390-7.

    Article  CAS  PubMed  Google Scholar 

  9. •• Rosa RG, Goldani LZ, dos Santos RP. Association between adherence to an antimicrobial stewardship program and mortality among hospitalised cancer patients with febrile neutropaenia: a prospective cohort study. BMC Infect Dis. 2014;14:286. doi:10.1186/1471-2334-14-286. A prospective observational study identified that patients receiving local protocol-recommended therapy for febrile neutropenia had reduced mortality in comparison to patients who were not treated according to the protocol.

    Article  PubMed  PubMed Central  Google Scholar 

  10. • Tavakoli-Ardakani M, Ghassemi S, Alizadeh AM, Salamzadeh J, Ghadiani M, Ghassemi S. Effects of pharmacist intervention on the utilization of vancomycin in a teaching hospital. Iran J Pharm Res. 2015;14(4):1281–8. A pharmacist intervention to increase adherence to vancomycin-use guidelines resulted in significant declines in inappropriate use and improvements in patient outcomes.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Wright JD, Neugut AI, Ananth CV, Lewin SN, Wilde ET, Lu YS, et al. Deviations from guideline-based therapy for febrile neutropenia in cancer patients and their effect on outcomes. JAMA Intern Med. 2013;173(7):559–68. doi:10.1001/jamainternmed.2013.2921.

    Article  PubMed  PubMed Central  Google Scholar 

  12. • Keng MK, Thallner EA, Elson P, Ajon C, Sekeres J, Wenzell CM, et al. Reducing time to antibiotic administration for febrile neutropenia in the emergency department. J Oncol Pract. 2015;11(6):450–5. doi:10.1200/JOP.2014.002733. Use of a hospital-specific pathway for febrile neutropenia in the emergency department was associated with significant reductions in time to antibiotic administration.

    Article  PubMed  Google Scholar 

  13. •• Pakakasama S, Surayuthpreecha K, Pandee U, Anurathapan U, Maleewan V, Udomsubpayakul U, et al. Clinical practice guidelines for children with cancer presenting with fever to the emergency room. Pediatr Int. 2011;53(6):902–5. doi:10.1111/j.1442-200X.2011.03363.x. Adherence with a clinical practice guideline for pediatric patients with febrile neutropenia in the emergency department was associated with significant improvements in time to antimicrobial administration, reduced septic shock, and reduced intensive care unit admission.

    Article  PubMed  Google Scholar 

  14. Nucci M, Landau M, Silveira F, Spector N, Pulcheri W. Application of the IDSA guidelines for the use of antimicrobial agents in neutropenic patients: impact on reducing the use of glycopeptides. Infect Control Hosp Epidemiol. 2001;22(10):651–3. doi:10.1086/501839.

    Article  CAS  PubMed  Google Scholar 

  15. Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62(4):e1–50. doi:10.1093/cid/civ933.

    Article  PubMed  Google Scholar 

  16. Patterson TF, Thompson GR 3rd, Denning DW, Fishman JA, Hadley S, Herbrecht R, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;63(4):e1–e60. doi:10.1093/cid/ciw326.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Pergam SA. Fungal pneumonia in patients with hematologic malignancies and hematopoietic cell transplantation. Clin Chest Med. 2017;38(2):279–94. doi:10.1016/j.ccm.2016.12.006.

    Article  PubMed  Google Scholar 

  18. Heil EL, Daniels LM, Long DM, Rodino KG, Weber DJ, Miller MB. Impact of a rapid peptide nucleic acid fluorescence in situ hybridization assay on treatment of Candida infections. Am J Health Syst Pharm. 2012;69(21):1910–4. doi:10.2146/ajhp110604. Use of the PNA-FISH Candida assay, in conjunction with antimicrobial stewardship efforts, led to signifnt improvements in time to organism identification, time to targeted antifungal therapy, and clearance of candidemia.

    Article  CAS  PubMed  Google Scholar 

  19. • Antworth A, Collins CD, Kunapuli A, Klein K, Carver P, Gandhi T, et al. Impact of an antimicrobial stewardship program comprehensive care bundle on management of candidemia. Pharmacotherapy. 2013;33(2):137–43. doi:10.1002/phar.1186. A comprehensvie antimicrobial stewardship bundle for patients with candidemia significantly improved antifungal use in patients with candidemia, including reductions in unecessary duration of therapy and antifungal selection.

    Article  PubMed  Google Scholar 

  20. Marzolini MA, Thomson KJ, Peggs KS. Antifungal stewardship: towards defining safe stop** criteria for therapeutic oral azoles. Br J Haematol. 2016;172(2):285–7. doi:10.1111/bjh.13474.

    Article  PubMed  Google Scholar 

  21. Dignan FL, Evans SO, Ethell ME, Shaw BE, Davies FE, Dearden CE, et al. An early CT-diagnosis-based treatment strategy for invasive fungal infection in allogeneic transplant recipients using caspofungin first line: an effective strategy with low mortality. Bone Marrow Transplant. 2009;44(1):51–6. doi:10.1038/bmt.2008.427.

    Article  CAS  PubMed  Google Scholar 

  22. •• Sun WC, Hsu PI, Yu HC, Lin KH, Tsay FW, Wang HM, et al. The compliance of doctors with viral hepatitis B screening and antiviral prophylaxis in cancer patients receiving cytotoxic chemotherapy using a hospital-based screening reminder system. PLoS One. 2015;10(2):e0116978. doi:10.1371/journal.pone.0116978. A computerized alert significantly improved the rate of screening and appropriate prophylaxis for Hepatitis B virus in cancer patients in an endemic area.

    Article  PubMed  PubMed Central  Google Scholar 

  23. El Chaer F, Shah DP, Chemaly RF. How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients. Blood. 2016;128(23):2624–36. doi:10.1182/blood-2016-06-688432.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Kakiuchi S, Tsuji M, Nishimura H, Yoshikawa T, Wang L, Takayama-Ito M, et al. Association of the emergence of acyclovir-resistant herpes simplex virus type 1 with prognosis in hematopoietic stem cell transplantation patients. J Infect Dis. 2017;215(6):865–73. doi:10.1093/infdis/jix042.

    Article  PubMed  Google Scholar 

  25. Chemaly RF, Aitken SL, Wolfe CR, Jain R, Boeckh MJ. Aerosolized ribavirin: the most expensive drug for pneumonia. Transpl Infect Dis. 2016;18(4):634–6. doi:10.1111/tid.12551.

    Article  CAS  PubMed  Google Scholar 

  26. Goldman JL, Ross RK, Lee BR, Newland JG, Hersh AL, Kronman MP, et al. Variability in antifungal and antiviral use in hospitalized children. Infect Control Hosp Epidemiol. 2017;38(6):743–6. doi:10.1017/ice.2017.40.

    Article  PubMed  Google Scholar 

  27. Chen CH, Yang PM, Huang GT, Lee HS, Sung JL, Sheu JC. Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants. J Formos Med Assoc. 2007;106(2):148–55. doi:10.1016/S0929-6646(09)60231-X.

    Article  PubMed  Google Scholar 

  28. Gomes MZ, Jiang Y, Mulanovich VE, Lewis RE, Kontoyiannis DP. Effectiveness of primary anti-aspergillus prophylaxis during remission induction chemotherapy of acute myeloid leukemia. Antimicrob Agents Chemother. 2014;58(5):2775–80. doi:10.1128/AAC.01527-13.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Shah DN, Yau R, Weston J, Lasco TM, Salazar M, Palmer HR, et al. Evaluation of antifungal therapy in patients with candidaemia based on susceptibility testing results: implications for antimicrobial stewardship programmes. J Antimicrob Chemother. 2011;66(9):2146–51. doi:10.1093/jac/dkr244.

    Article  CAS  PubMed  Google Scholar 

  30. Garey KW, Pai MP, Suda KJ, Turpin RS, Rege MD, Mingo DE, et al. Inadequacy of fluconazole dosing in patients with candidemia based on Infectious Diseases Society of America (IDSA) guidelines. Pharmacoepidemiol Drug Saf. 2007;16(8):919–27. doi:10.1002/pds.1365.

    Article  CAS  PubMed  Google Scholar 

  31. Mylonakis E, Clancy CJ, Ostrosky-Zeichner L, Garey KW, Alangaden GJ, Vazquez JA, et al. T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial. Clin Infect Dis. 2015;60(6):892–9. doi:10.1093/cid/ciu959.

    Article  PubMed  Google Scholar 

  32. Aitken SL, Beyda ND, Shah DN, Palmer HR, Lasco TM, Koo H, et al. Clinical practice patterns in hospitalized patients at risk for invasive candidiasis: role of antifungal stewardship programs in an era of rapid diagnostics. Ann Pharmacother. 2014;48(6):683–90. doi:10.1177/1060028014529928.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Michigan Medicine, Department of Pharmacy Services, University of Michigan, College of Pharmacy, 1500 E Medical Center Dr, UH B2 D301/0008, Ann Arbor, MI, 48109, USA

    Maressa Santarossa PharmD, BCPS & Jerod Nagel PharmD, BCPS (AQID)

  2. Division of Pharmacy, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 0090, Houston, TX, 77030, USA

    Samuel L. Aitken PharmD, BCPS (AQID)

Authors
  1. Maressa Santarossa PharmD, BCPS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Samuel L. Aitken PharmD, BCPS (AQID)
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jerod Nagel PharmD, BCPS (AQID)
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jerod Nagel PharmD, BCPS (AQID).

Ethics declarations

Conflict of interest

Dr. Maressa Santarossa declares that she has no conflicts of interest. Dr. Samuel L. Aitken declares that he has no conflicts of interest. Dr. Jerod Nagel declares that he has no conflicts of interest.

Human and animal rights and informed consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Antimicrobial Stewardship

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Santarossa, M., Aitken, S.L. & Nagel, J. Improving Antimicrobial Stewardship in Cancer Patients Through Implementation of Clinical Guidelines. Curr Treat Options Infect Dis 9, 333–346 (2017). https://doi.org/10.1007/s40506-017-0131-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40506-017-0131-y

Keywords

Search

Navigation